Dr. Mark Francis Duvernois is a El Paso, Texas based Oral and Maxillofacial Surgeon who is specialized in Oral and Maxillofacial Surgery. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 7211 N Mesa St, Suite 1 South, El Paso. Patients can reach him at 915-833-2827.
Dr. Mark Francis Duvernois deals with the diagnosis, surgical and adjunctive treatment of diseases, injuries and defects involving both the functional and esthetic aspects of the hard and soft tissues of the oral and maxillofacial region.
Complete Profile:
Dr. Mark Francis Duvernois speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Name:
Dr. Mark Francis Duvernois
Specialization:
Oral and Maxillofacial Surgeon
Gender:
Male
Credentials:
D.D.S.
Accepts Medicare Assignment:
May Accept
Practice Address:
7211 N Mesa St, Suite 1 South, El Paso, Texas, 79912-3611
Phone:
915-833-2827
Fax:
915-587-8995
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
PAC ID:
3375530587
Enrollment ID:
I20160223001036
NPI Number:
1245284306
NPI Enumeration Date:
20 May, 2006
NPI Last Update On:
08 Jul, 2007
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
5428 Cactus Hill Dr, El Paso, Texas
Zip:
79912-6304
Phone Number:
915-875-0110
Fax Number:
915-587-8995
Patients can reach Dr. Mark Francis Duvernois at 7211 N Mesa St, Suite 1 South, El Paso, Texas or can call to book an appointment on 915-833-2827. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.